Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma. Issue 2 (May 2015)
- Record Type:
- Journal Article
- Title:
- Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma. Issue 2 (May 2015)
- Main Title:
- Clinical implementation and range evaluation of in vivo PET dosimetry for particle irradiation in patients with primary glioma
- Authors:
- Nischwitz, Sebastian P.
Bauer, Julia
Welzel, Thomas
Rief, Harald
Jäkel, Oliver
Haberer, Thomas
Frey, Kathrin
Debus, Jürgen
Parodi, Katia
Combs, Stephanie E.
Rieken, Stefan - Abstract:
- <abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st075">Abstract</title> <sec> <title id="st080">Purpose</title> <p id="sp0005">The physical and biological properties of ion-beams offer various advantages in comparison to conventional radiotherapy, though uncertainties concerning quality assurance are still left. Due to the inverted depth dose profile, range accuracy is of paramount importance.</p> <p id="sp0010">We investigated the range deviations between planning simulation and post-fractional PET/CT measurement from particle therapy in primary glioblastoma.</p> </sec> <sec> <title id="st085">Methods and materials</title> <p id="sp0015">20 patients with glioblastoma undergoing particle therapy at our institution were selected. 10 received a proton-boost, 10 a carbon-ion-boost in addition to standard treatment. After two fractions, we performed a PET/CT-scan of the brain. We compared the resulting range deviation based on the Most-likely-shift method between the two measurements, and the measurements with corresponding expectations, calculated with the Monte-Carlo code FLUKA.</p> </sec> <sec> <title id="st090">Results</title> <p id="sp0020">A patient's two measurements deviated by 0.7 mm (±0.7 mm). Overall comparison between measurements and simulation resulted in a mean range deviation of 3.3 mm (±2.2 mm) with significant lower deviations in the <sup>12</sup>C-arm.</p> </sec> <sec> <title id="st095">Conclusion</title> <p id="sp0025">The used planning<abstract xml:lang="en" abstract-type="author" id="ab005"> <title id="st075">Abstract</title> <sec> <title id="st080">Purpose</title> <p id="sp0005">The physical and biological properties of ion-beams offer various advantages in comparison to conventional radiotherapy, though uncertainties concerning quality assurance are still left. Due to the inverted depth dose profile, range accuracy is of paramount importance.</p> <p id="sp0010">We investigated the range deviations between planning simulation and post-fractional PET/CT measurement from particle therapy in primary glioblastoma.</p> </sec> <sec> <title id="st085">Methods and materials</title> <p id="sp0015">20 patients with glioblastoma undergoing particle therapy at our institution were selected. 10 received a proton-boost, 10 a carbon-ion-boost in addition to standard treatment. After two fractions, we performed a PET/CT-scan of the brain. We compared the resulting range deviation based on the Most-likely-shift method between the two measurements, and the measurements with corresponding expectations, calculated with the Monte-Carlo code FLUKA.</p> </sec> <sec> <title id="st090">Results</title> <p id="sp0020">A patient's two measurements deviated by 0.7 mm (±0.7 mm). Overall comparison between measurements and simulation resulted in a mean range deviation of 3.3 mm (±2.2 mm) with significant lower deviations in the <sup>12</sup>C-arm.</p> </sec> <sec> <title id="st095">Conclusion</title> <p id="sp0025">The used planning concepts display the actual dose distributions adequately. The carbon ion group's results are below the used PTV safety margins (3 mm). Further adjustments to the simulation are required for proton irradiations. Some anatomical situations require particular attention to ensure highest accuracy and safety.</p> </sec> </abstract> … (more)
- Is Part Of:
- Radiotherapy and oncology. Volume 115:Issue 2(2015:May)
- Journal:
- Radiotherapy and oncology
- Issue:
- Volume 115:Issue 2(2015:May)
- Issue Display:
- Volume 115, Issue 2 (2015)
- Year:
- 2015
- Volume:
- 115
- Issue:
- 2
- Issue Sort Value:
- 2015-0115-0002-0000
- Page Start:
- 179
- Page End:
- 185
- Publication Date:
- 2015-05
- Subjects:
- Oncology -- Periodicals
Radiotherapy -- Periodicals
Tumors -- Periodicals
Medical Oncology -- Periodicals
Neoplasms -- radiotherapy -- Periodicals
Radiotherapy -- Periodicals
Radiothérapie -- Périodiques
Cancérologie -- Périodiques
Tumeurs -- Périodiques
Electronic journals
616.9940642 - Journal URLs:
- http://www.sciencedirect.com/science/journal/01678140 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/01678140 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/01678140 ↗
http://www.estro.org/ ↗
http://www.elsevier.com/journals ↗
http://www.journals.elsevier.com/radiotherapy-and-oncology/ ↗ - DOI:
- 10.1016/j.radonc.2015.03.022 ↗
- Languages:
- English
- ISSNs:
- 0167-8140
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 7240.790000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3855.xml